Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CAP-100
i
Other names:
CAP-100, CAP 100
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Catapult Therap
Drug class:
CCR7 receptor antagonist
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCR7 expresion
Chronic Lymphocytic Leukemia
CCR7 expresion
Chronic Lymphocytic Leukemia
CAP-100
Sensitive: C3 – Early Trials
CAP-100
Sensitive
:
C3
CAP-100
Sensitive: C3 – Early Trials
CAP-100
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login